Vaxxinova Purchases Newport Laboratories

Cattle on pasture.
Cattle on pasture.
(File Photo)

Vaxxinova announces it has purchased Newport Laboratories, a company that manufactures custom-made vaccines for swine and cattle, from Boehringer Ingelheim.

About 100 people work at Newport Laboratories in Worthington, Minn. They help veterinarians and livestock producers address animal health issues through diagnostic testing and production of autogenous, or custom-made, vaccines.

Vaxxinova CEO Victor van Solinge said his team is committed to a smooth transition to support of Newport Laboratories customers. "We are proud to add Newport Laboratories to the group of Vaxxinova companies. It is a perfect fit with our strategy to grow and improve our products and services for livestock producers and veterinarians," he said. "Newport and Vaxxinova US (previously known as Epitopix) have complementary portfolios and similar company cultures. We are confident that our customers will benefit from this new combination." Terms of the deal were not disclosed.

"Newport Laboratories has a proud history of helping protect cattle and swine from disease through custom-made vaccines, and this transaction lets Newport Laboratories continue that legacy," said Steve Boren, Vice President of the Livestock business at Boehringer Ingelheim Animal Health USA Inc. "I am pleased that Vaxxinova is purchasing Newport Laboratories and believe that Vaxxinova can realize the full potential of the custom-made vaccine business. "Additionally, the divesture allows Boehringer Ingelheim to continue its focus on helping producers and veterinarians with our full array of well-established commercial brands based on our deep expertise in cattle and swine."

Jim Sandstrom, DVM, managing director of Vaxxinova US said that Vaxxinova hopes to ensure a fast, seamless transfer. "Our aim is to have zero disruptions in product supply and service, and to begin delivering synergies to customers as quickly as possible" he said. "In addition, Vaxxinova US customers will also benefit from Newport Laboratories' state of art diagnostic center, which provides excellent diagnostic services to the industry."

 

Latest News

Fairlife Breaks Ground on $650 Million Facility in New York
Fairlife Breaks Ground on $650 Million Facility in New York

Fairlife is known for its value-added dairy products, such as ultra-filtered milk, protein shakes and lactose-free milk. Soon, the company will be producing these popular products at its upcoming facility in N.Y.

Cassady Joins Wagyu Association
Cassady Joins Wagyu Association

American Wagyu Association names Jerry Cassady as new Executive Director effective May 1.

Endovac Names New National Sales Director
Endovac Names New National Sales Director

Darren Schmadeke is leading the Endovac sales team as it builds new opportunities for the company's products.

Liver Abscesses in Beef-on-Dairy Cattle are Costing Packers Big Money
Liver Abscesses in Beef-on-Dairy Cattle are Costing Packers Big Money

This growing beef-on-dairy health problem is costing packers two major things – time and money.

Can High Cattle Prices Pay for Mistakes?
Can High Cattle Prices Pay for Mistakes?

High prices are a welcome change for cattle producers, but it’s important to remember that higher prices mean mistakes cost more than when prices are low, says a University of Missouri Extension livestock specialist.

  New Dean Selected for UT College of Veterinary Medicine
New Dean Selected for UT College of Veterinary Medicine

Dr. Paul J. Plummer, DVM and PhD, a native of Sevierville, Tenn., has been named the next dean for the University of Tennessee College of Veterinary Medicine.